Agerafenib Uses, Dosage, Side Effects and more
Agerafenib is under investigation in clinical trial NCT03052569 (Expanded Access to RXDX-105 for Cancers With RET Alterations).
| Trade Name | Agerafenib |
| Generic | Agerafenib |
| Agerafenib Other Names | Agerafenib |
| Type | |
| Formula | C24H22F3N5O5 |
| Weight | Average: 517.465 Monoisotopic: 517.157303317 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
